Silvercrest Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.92M | Hold |
135,915
| – | – | 0.05% | 378 |
|
|
2025
Q1 | $6.12M | Sell |
135,915
-785
| -0.6% | -$35.4K | 0.04% | 380 |
|
|
2024
Q4 | $5.65M | Sell |
136,700
-1,347
| -1% | -$55.7K | 0.04% | 400 |
|
|
2024
Q3 | $5.38M | Sell |
138,047
-82,443
| -37% | -$3.22M | 0.04% | 374 |
|
|
2024
Q2 | $7.54M | Buy |
220,490
+57,673
| +35% | +$1.97M | 0.05% | 318 |
|
|
2024
Q1 | $4.09M | Buy |
162,817
+63,871
| +65% | +$1.6M | 0.03% | 423 |
|
|
2023
Q4 | $2.92M | Sell |
98,946
-53,464
| -35% | -$1.58M | 0.02% | 453 |
|
|
2023
Q3 | $4.82M | Sell |
152,410
-81,858
| -35% | -$2.59M | 0.04% | 366 |
|
|
2023
Q2 | $6.06M | Buy |
234,268
+32,888
| +16% | +$851K | 0.04% | 337 |
|
|
2023
Q1 | $4.84M | Hold |
201,380
| – | – | 0.04% | 354 |
|
|
2022
Q4 | $3.93M | Buy |
201,380
+41,343
| +26% | +$806K | 0.03% | 378 |
|
|
2022
Q3 | $3.36M | Sell |
160,037
-4,350
| -3% | -$91.4K | 0.03% | 386 |
|
|
2022
Q2 | $3.2M | Sell |
164,387
-7,528
| -4% | -$146K | 0.02% | 403 |
|
|
2022
Q1 | $3.79M | Sell |
171,915
-114,325
| -40% | -$2.52M | 0.02% | 412 |
|
|
2021
Q4 | $4.57M | Buy |
+286,240
| New | +$4.57M | 0.03% | 392 |
|